InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Morabito Christopher, Directeur Médical. Insider active across 1 companies, notably Fulcrum Therapeutics, Inc.. Aggregated, 2 reports have been published. Total volume traded: €17k. The latest transaction was disclosed on 28 June 2021 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations2 total
€8,4471,100 shares@ €7.67880.0019% mcap100.0% of flow
Common Stock
SEC:0000899243-21-026557·
Ideal exit: 25 Mar 2022 (T+270)
€8,4471,100 shares@ €7.67880.0019% mcap50.0% of flow
Common Stock
SEC:0000899243-21-026557:0·
Ideal exit: 25 Mar 2022 (T+270)
2 of 2 declarations
About Morabito Christopher
Christopher Morabito is the Chief Medical Officer at Fulcrum Therapeutics, Inc. In this role, he is responsible for leading the company's clinical initiatives and medical research. With a strong background in the biopharmaceutical sector, Christopher plays a key role in developing innovative therapies. His expertise is essential to ensure regulatory compliance and the effectiveness of clinical trials at Fulcrum.
